Alan Nurden: How P-Selectin Inhibition Can Help Thrombus Resolution
Alan Nurden, Emeritus Research Director at CNRS, Co-Founder of the French National Reference Centre for Inherited Platelet Disorders (CRPP), shared a post on LinkedIn, about a recent article by Julia B. Kral-Pointner et al, published in AHA/ASA Journals:
“A belated acquaintance for me of a highly recommended study showing how P-Selectin inhibition can help thrombus resolution in mouse models.
This is thought-provoking, but could not this be a strategy to consider to resolve thrombi (arterial or venous) in patients with Glanzmann thrombasthenia and whose platelets lack the alphaIIbbeta3 integrin.
Worth looking at in an appropriate model.”
Title: Reduced Monocyte and Neutrophil Infiltration and Activation by P-Selectin/CD62P Inhibition Enhances Thrombus Resolution in Mice
Authors: Julia B. Kral-Pointner, Patrick Haider, Petra L. Szabo, Manuel Salzmann, Mira Brekalo, Karl H. Schneider, Waltraud C. Schrottmaier, Christoph Kaun, Sonja Bleichert, Attila Kiss, Romana Sickha, Christian Hengstenberg, Kurt Huber, Christine Brostjan, Helga Bergmeister , Alice Assinger, Bruno K. Podesser, Johann Wojta, and Philipp Hohensinner
Read the Full Article on AHA/ASA Journals.
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian